COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 157 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,406 | +17.9% | 17,960 | +13.4% | 0.00% | – |
| Q2 2023 | $340,423 | -16.8% | 15,841 | -7.1% | 0.00% | – |
| Q1 2023 | $409,245 | -0.2% | 17,059 | -3.5% | 0.00% | – |
| Q4 2022 | $410,014 | +44.4% | 17,673 | -0.2% | 0.00% | – |
| Q3 2022 | $284,000 | -0.4% | 17,701 | +9.9% | 0.00% | – |
| Q2 2022 | $285,000 | -12.6% | 16,102 | +0.5% | 0.00% | – |
| Q1 2022 | $326,000 | +34.7% | 16,028 | +23.6% | 0.00% | – |
| Q4 2021 | $242,000 | -29.2% | 12,970 | -25.1% | 0.00% | – |
| Q3 2021 | $342,000 | -1.4% | 17,310 | +17.9% | 0.00% | – |
| Q2 2021 | $347,000 | +4.2% | 14,679 | +4.4% | 0.00% | – |
| Q1 2021 | $333,000 | +16.0% | 14,058 | -1.8% | 0.00% | – |
| Q4 2020 | $287,000 | +24.8% | 14,316 | +29.8% | 0.00% | – |
| Q3 2020 | $230,000 | +21.1% | 11,027 | +1.6% | 0.00% | – |
| Q2 2020 | $190,000 | +13.8% | 10,854 | +6.2% | 0.00% | – |
| Q1 2020 | $167,000 | +16600.0% | 10,224 | +14505.7% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
| Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
| OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
| Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
| CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
| Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
| OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
| Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |